EASME

The Glenside Group is a farm equipment supplier. Founded in Scotland in 1982, they are committed to improving customer profitability by increasing the natural fertility of their farms, throughout the UK, Ireland, and Overseas.

Nova Innovation Ltd. is a tidal energy company founded in 2009 and based in Edinburgh, United Kingdom, with additional offices in Leith, Caernarfon, and Shetland. The company specializes in designing, building, and operating underwater tidal turbines that provide clean, predictable electricity while minimizing visual impact and harmonizing with the marine environment. Nova Innovation develops sites for arrays of tidal turbines and is dedicated to reducing reliance on fossil fuels for future generations. With a focus on local supply chains, the company engages coastal communities to enhance the success of its tidal power projects. Nova Innovation gained recognition for deploying the world's first offshore tidal array, earning awards for its contributions to low-carbon innovation and sustainable energy solutions.

Ingenza, established in 2002, specializes in industrial biotechnology and synthetic biology. The company, spun out from the University of Edinburgh, focuses on improving yields of unnatural amino acids and amines through microbial production technology modification and commercialization. Ingenza offers efficient, scalable bioprocesses for manufacturing chemicals, biologics, pharmaceuticals, and biofuels from sustainable sources. Its team of experts in molecular biology, gene expression, directed evolution, fermentation, and process development work together to provide innovative solutions for diverse client needs.

Gaia-Wind is a specialist designer and manufacturer of small wind turbines. Originally a Danish company established in 1993, its global headquarters are now located in Glasgow, Scotland, from where it manufactures and distribute its turbines worldwide. Its 133-11kW turbine benefits from more than 20 years of Danish design experience, and Gaia-Wind continues to invest in its research and development. Over 500 of its wind turbines have been installed worldwide with a combined operational history of more than 1500 years.

Equine Register is the leading provider of national identification, registration, and intelligence services to the equine industry and governments. Equine Register is Defra’s partner in delivering and managing the Central Equine Database (CED) on behalf of the UK Government and Devolved Administrations. Working closely with the equine sector, Equine Register has developed a series of bespoke digital tools that enable secure, real-time access to vital animal identification and traceability data. These tools promote compliance and good owner practices, increase animal welfare and value, and help secure the human food-chain and national borders, all whilst reducing criminal activity. Equine Register’s cutting-edge patented technology will position the UK at the forefront of animal traceability and biosecurity, playing a key role in the launch of Brand Britain following Brexit.

Reminova Ltd. is a dental health technology company based in Perth, United Kingdom, founded in 2014. The company specializes in developing innovative solutions for tooth enamel repair, focusing on the treatment of early-stage tooth decay, also known as caries. Reminova's flagship offering is an electrically assisted enhanced remineralization technology that allows dentists to repair damaged enamel quickly and painlessly, without the need for drilling, fillings, or anesthetic injections. This natural preventative treatment aims to improve oral healthcare by enabling patients to maintain strong and healthy teeth throughout their lives. In addition to its core enamel repair solutions, Reminova provides a range of products for various dental applications, including tooth whitening, endodontics, restorative treatments, hypersensitivity, and orthodontics. The company markets its products across several countries, including the United States, Canada, Brazil, Mexico, the United Kingdom, Germany, France, and Japan.

Palpation Diagnostics develops ProstaPalp a medical device to identify and diagnosise prostate cancer faster, cheaper and less painful. It is a team of urologists and engineers working to use stiffness measurement to identify tissue type in the prostate gland. Our product could greatly reduce the number of patients who receive unnecessary biopsies, and make the diagnostic pathway more cost-effective. The technology was developed at Heriot-Watt University and the University of Edinburgh, and will soon be spun out. We are looking for seed round investment to help us to reach our next development milestone.

AvantiCell Science Limited is a UK-based company that specializes in developing and providing cell-based products and services for the pharmaceutical, agri-biotechnology, and healthcare industries. Founded in 2006 and located in Ayr, the company offers a diverse range of human and animal primary cells, cell lines, and cell-based assays designed for drug discovery, biomedical research, and natural product testing. AvantiCell's offerings include ready-to-use cell-based analysis systems that facilitate the evaluation of bio-activity and bio-safety across various materials, including pharmaceuticals and medical devices. The company also provides customized assay development services, enabling clients to adapt assays to their specific needs. With a focus on advanced cell culture technology, AvantiCell Science ensures that its products and services are accessible and relevant, making cell-based analysis efficient and effective for a wide range of applications.

Smarter Grid Solutions Ltd. is a prominent smart grid technology company based in Glasgow, United Kingdom, with additional offices in London and New York. Founded in 2008, the company specializes in developing and deploying active network management (ANM) products aimed at integrating Distributed Energy Resources (DER) into electricity grids. Its key offerings include ANM Strata, ANM 100, ANM 50, and CONNECT+, which facilitate the connection, control, and optimization of various DER types. These products enable electricity distribution companies to manage grid-connected resources effectively, supporting high renewable energy penetration and facilitating net-zero emission electricity. Additionally, Smarter Grid Solutions provides tools for capacity analysis and grid connection assessments, alongside consultancy services in strategic planning and smart grid training. The company collaborates with a range of power companies and utilities across the UK, Europe, and the US, contributing to both rural and urban smart grid projects.

Calcivis is a privately held company founded in 2012 and headquartered in Edinburgh, Scotland. It specializes in developing and commercializing innovative dental imaging technology aimed at addressing significant unmet needs in dentistry. The company's core product is a platform designed to revolutionize the treatment of tooth decay by enabling dentists to visualize active decay early, potentially preventing cavities that would otherwise require drilling and filling. Calcivis operates a virtual development model, collaborating with contract research and manufacturing organizations predominantly based in Scotland.

Cytosystems Ltd. is a pathology company based in Aberdeen, United Kingdom, specializing in the development of non-invasive screening and diagnostic test solutions for bladder and prostate cancer. Founded in 2004, the company offers various innovative technologies designed to enhance cancer detection and management. Its flagship product, BladderLight™, is an automated digital pathology solution that incorporates a big data systems approach to diagnose and monitor bladder cancer. Cytosystems has also created two patent-pending technologies: a point-of-care cell collection device that improves analyte quality and an artificial intelligence software that objectively classifies urothelial cells as cancer positive or negative. These advancements provide healthcare practitioners with sensitive and specific alternatives to traditional invasive tests, facilitating better clinical decision-making in the management of urological cancers.

AvantiCell Science Limited is a UK-based company that specializes in developing and providing cell-based products and services for the pharmaceutical, agri-biotechnology, and healthcare industries. Founded in 2006 and located in Ayr, the company offers a diverse range of human and animal primary cells, cell lines, and cell-based assays designed for drug discovery, biomedical research, and natural product testing. AvantiCell's offerings include ready-to-use cell-based analysis systems that facilitate the evaluation of bio-activity and bio-safety across various materials, including pharmaceuticals and medical devices. The company also provides customized assay development services, enabling clients to adapt assays to their specific needs. With a focus on advanced cell culture technology, AvantiCell Science ensures that its products and services are accessible and relevant, making cell-based analysis efficient and effective for a wide range of applications.

Nova Innovation Ltd. is a tidal energy company founded in 2009 and based in Edinburgh, United Kingdom, with additional offices in Leith, Caernarfon, and Shetland. The company specializes in designing, building, and operating underwater tidal turbines that provide clean, predictable electricity while minimizing visual impact and harmonizing with the marine environment. Nova Innovation develops sites for arrays of tidal turbines and is dedicated to reducing reliance on fossil fuels for future generations. With a focus on local supply chains, the company engages coastal communities to enhance the success of its tidal power projects. Nova Innovation gained recognition for deploying the world's first offshore tidal array, earning awards for its contributions to low-carbon innovation and sustainable energy solutions.

Vascular Flow Technologies Ltd. is a medical devices company based in Dundee, United Kingdom, focused on the research, development, and commercialization of vascular devices that leverage an innovative understanding of blood flow dynamics, specifically Spiral Laminar Flow technology. This technology is designed to restore the body's natural blood transport mechanisms, especially in cases where patients require prosthetic vascular grafts to repair diseased veins and arteries. Vascular Flow offers products such as Spiral Flow prosthetic vascular grafts and arteriovenous vascular access grafts, which are particularly beneficial for patients undergoing hemodialysis, as they help prevent disease progression and improve overall patient outcomes in vascular interventions. Established in 1998 and initially known as Tayside Flow Technologies Limited, the company rebranded in 2012 and serves a global market, aiming to enhance the efficacy of vascular treatments for surgeons, caregivers, and patients alike.